ABDX
GOODAbingdon Health Secures €2m Companion Diagnostic Contract
The healthcare diagnostics company has secured a €2m contract to develop and gain regulatory approval for a companion diagnostic test, leveraging its CDMO capabilities.
Abingdon Health
7.50GBX
7.14%
Market Cap
14.21M
Volume
494
0% of avg
P/E Ratio
1.88
EPS (TTM)
0.04
Beta
0.22
Day Range
7.23p - 7.50p
52 Week Range
5.50p7.50p11.50p
7.50p
Upcoming Events
ABDX
NEUTRALAbingdon Health Provides Update on Strategic Partnership with FOFH
The healthcare company announces an update on its strategic partnership with a US-based firm, including the appointment of an Abingdon executive to FOFH's board.
ABDX
NEUTRALAbingdon Health partners to develop avian flu lateral flow test
The diagnostics company has entered a co-development, manufacturing and commercialisation agreement with Okos Diagnostics to adapt an avian flu lateral flow test for animal and human health applications.
ABDX
NEUTRALAbingdon Health Awards Options Under LTIP
The healthcare company has awarded share options to its directors and senior team under a long-term incentive plan.
ABDX
NEUTRALAbingdon Health Announces Directorate Changes
The healthcare company announces changes to its leadership team, including the appointment of a new Non-Executive Director.
ABDX
BADAbingdon Health Reports Widening Losses Despite Revenue Growth in Half-Year Results
The diagnostics firm reported increased revenue but widening losses in its half-year results. Despite new contracts and market expansion, core segment revenue declined and profitability remains a distant goal, with ongoing market challenges and execution risks.
ABDX
NEUTRALAbingdon Health Plc Provides Notice of Results
The healthcare diagnostics company has announced it will release its interim results and host an investor presentation in the coming weeks.
ABDX
NEUTRALAbingdon Health to Launch Innovative Saliva-Based Pregnancy Test in Germany
The healthcare company is expanding the distribution of its innovative saliva-based pregnancy test to Germany and other European markets.
ABDX
GOODAbingdon Health Awarded Funding for Malaria Diagnostic Test Development
The healthcare company has been awarded funding to develop a rapid diagnostic test for malaria, in partnership with leading research institutions. This new test aims to improve malaria control efforts in sub-Saharan Africa.
ABDX
GOODAbingdon Health wins major diagnostics contract
The diagnostics company has won a major contract worth over £500k, showcasing its expanded service capabilities following a recent acquisition.